Skip to main content

Table 4 Sleep quality subscores comparison between grades of MAFLD

From: Lifestyle determinants as predictor of severity of metabolic associated fatty liver disease (MAFLD)

 

Mild steatosis (N = 28)

Moderate-severe steatosis (N = 49)

*P value

r(Spearman correlation)**

#P value

Subjective sleep quality

N(%)

N(%)

0.798

0.052

0.656

 Very good

14(50)

23(46.9)

   

 Fairly good

10(35.7)

16(32.7)

   

 Fairly bad

4(14.3)

10(20.4)

   

Sleep latency

N(%)

N(%)

0.025

0.203

0.077

 Very good

12(42.9)

18(36.7)

   

 Fairly good

5(17.9)

2(4.1)

   

 Fairly bad

6(21.4)

6(12.2)

   

 Very bad

5(17.9)

23(46.9)

   

Sleep duration score

N(%)

N(%)

0.607

− .060-

0.602

 Very good

9(32.1)

16(32.7)

   

 Fairly good

6(21.4)

16(32.7)

   

 Fairly bad

11(39.3)

13(26.5)

   

 Very bad

2(7.1)

4(8.2)

   

Habitual sleep efficiency

N(%)

N(%)

0.072

.300

0.008

 Very good

18(64.3)

17(34.7)

   

 Fairly good

8(28.6)

21(42.9)

   

 Fairly bad

2(7.1)

9(18.4)

   

 Very bad

0(0)

2(4.1)

   

Sleep disturbance

N(%)

N(%)

0.006

.338

0.003

 Very good

3(10.7)

1(2)

   

 Fairly good

21(75)

26(53.1)

   

 Fairly bad

4(14.3)

22(44.9)

   

Sleep medication use

N(%)

N(%)

1

0.087

0.453

 No

28(100)

48(98)

   

 Yes

0(0)

1(2)

   

Daytime dysfunction

N(%)

N(%)

0.013

.363

0.001

 Very good

13(46.4)

7(14.3)

   

 Fairly good

7(25)

12(24.5)

   

 Fairly bad

6(21.4)

20(40.8)

   

 Very bad

2(7.1)

10(20.4)

   
  1. *Test of significance chi-square P ≤ 0.05 statistically significant
  2. **Spearman correlation test
  3. #p value of Spearman correlation test